N4 Pharma Plc (LON:N4P – Get Free Report)’s stock price was up 8.3% during trading on Wednesday . The stock traded as high as GBX 0.65 ($0.01) and last traded at GBX 0.65 ($0.01). Approximately 230,214 shares were traded during trading, a decline of 81% from the average daily volume of 1,197,753 shares. The stock had previously closed at GBX 0.60 ($0.01).
N4 Pharma Stock Up 8.3 %
The firm has a 50 day moving average of GBX 0.63 and a two-hundred day moving average of GBX 0.58. The stock has a market capitalization of £2.57 million, a PE ratio of -55.00 and a beta of -0.37. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than N4 Pharma
- How to buy stock: A step-by-step guide for beginners
- Holiday Cheer or Market Fear: Navigating the Year-End Rally
- What Makes a Stock a Good Dividend Stock?
- Gold vs. Silver: Profit Opportunities in the Widening Spread
- Health Care Stocks Explained: Why You Might Want to Invest
- Semler Stock Surges Over 130% in November: A New Bitcoin Play?
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
